Hunan Er-Kang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Hunan Er-Kang Pharmaceutical has a total shareholder equity of CN¥4.8B and total debt of CN¥353.2M, which brings its debt-to-equity ratio to 7.4%. Its total assets and total liabilities are CN¥5.5B and CN¥686.0M respectively.
Key information
7.4%
Debt to equity ratio
CN¥353.21m
Debt
Interest coverage ratio | n/a |
Cash | CN¥535.19m |
Equity | CN¥4.78b |
Total liabilities | CN¥685.98m |
Total assets | CN¥5.46b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300267's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥620.2M).
Long Term Liabilities: 300267's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥65.8M).
Debt to Equity History and Analysis
Debt Level: 300267 has more cash than its total debt.
Reducing Debt: 300267's debt to equity ratio has increased from 1.8% to 7.4% over the past 5 years.
Debt Coverage: 300267's debt is well covered by operating cash flow (79.9%).
Interest Coverage: Insufficient data to determine if 300267's interest payments on its debt are well covered by EBIT.